Related references
Note: Only part of the references are listed.miR-96 exerts carcinogenic effect by activating AKT/GSK-3β/β-catenin signaling pathway through targeting inhibition of FOXO1 in hepatocellular carcinoma
Nanmu Yang et al.
CANCER CELL INTERNATIONAL (2019)
Estrogen Activation of G-Protein-Coupled Estrogen Receptor 1 Regulates Phosphoinositide 3-Kinase and mTOR Signaling to Promote Liver Growth in Zebrafish and Proliferation of Human Hepatocytes
Saireudee Chaturantabut et al.
GASTROENTEROLOGY (2019)
5-Hydroxytryptamine Receptor 1D Aggravates Hepatocellular Carcinoma Progression Through FoxO6 in AKT-Dependent and Independent Manners
Xueliang Zuo et al.
HEPATOLOGY (2019)
Prostate tumor neuroendocrine differentiation via EMT: The road less traveled
Haley Dicken et al.
ASIAN JOURNAL OF UROLOGY (2019)
The Long Noncoding RNA Cancer Susceptibility 9 and RNA Binding Protein Heterogeneous Nuclear Ribonucleoprotein L Form a Complex and Coregulate Genes Linked to AKT Signaling
Marcel Klingenberg et al.
HEPATOLOGY (2018)
The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation
Qiong Wu et al.
CELL DEATH & DISEASE (2018)
Alpha-fetoprotein inhibits autophagy to promote malignant behaviour in hepatocellular carcinoma cells by activating PI3K/AKT/mTOR signalling
Shanshan Wang et al.
CELL DEATH & DISEASE (2018)
Exosomal miRNAs as biomarkers in the diagnosis of liver disease
Sheng Wang et al.
BIOMARKERS IN MEDICINE (2017)
GOLM1 Modulates EGFR/RTK Cell-Surface Recycling to Drive Hepatocellular Carcinoma Metastasis
Qing-Hai Ye et al.
CANCER CELL (2016)
Tropomodulin-3 is essential in asymmetric division during mouse oocyte maturation
Yu-Jin Jo et al.
SCIENTIFIC REPORTS (2016)
Regulation of actin polymerization by tropomodulin-3 controls megakaryocyte actin organization and platelet biogenesis
Zhenhua Sui et al.
BLOOD (2015)
Tropomodulin3 is a novel Akt2 effector regulating insulin-stimulated GLUT4 exocytosis through cortical actin remodeling
Chun-Yan Lim et al.
Nature Communications (2015)
PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation
Valeria Iansante et al.
NATURE COMMUNICATIONS (2015)
PKD1 Phosphorylation-Dependent Degradation of SNAIL by SCF-FBXO11 Regulates Epithelial-Mesenchymal Transition and Metastasis
Hanqiu Zheng et al.
CANCER CELL (2014)
A Long Noncoding RNA Activated by TGF-β Promotes the Invasion-Metastasis Cascade in Hepatocellular Carcinoma
Ji-hang Yuan et al.
CANCER CELL (2014)
Differential Actin-regulatory Activities of Tropomodulin1 and Tropomodulin3 with Diverse Tropomyosin and Actin Isoforms*
Sawako Yamashiro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Mechanism of actin filament pointed-end capping by tropomodulin
Jampani Nageswara Rao et al.
SCIENCE (2014)
Recent Progress in Understanding, Diagnosing, and Treating Hepatocellular Carcinoma
Mary Maluccio et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
EMT and MET in Metastasis: Where Are the Cancer Stem Cells?
Thomas Brabletz
CANCER CELL (2012)
Tropomodulins: Pointed-end capping proteins that regulate actin filament architecture in diverse cell types
Sawako Yamashiro et al.
CYTOSKELETON (2012)
Cyclin G1-mediated epithelial-mesenchymal transition via phosphoinositide 3-kinase/Akt signaling facilitates liver cancer progression
Wen Wen et al.
HEPATOLOGY (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Tropomodulin Capping of Actin Filaments in Striated Muscle Development and Physiology
David S. Gokhin et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection
W. Alazawi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
ERβ Impedes Prostate Cancer EMT by Destabilizing HIF-1α and Inhibiting VEGF-Mediated Snail Nuclear Localization: Implications for Gleason Grading
Paul Mak et al.
CANCER CELL (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective
Alan P. Venook et al.
ONCOLOGIST (2010)
A Gene Expression Signature Associated with K-Ras Addiction Reveals Regulators of EMT and Tumor Cell Survival
Anurag Singh et al.
CANCER CELL (2009)
The Akt kinases Isoform specificity in metabolism and cancer
Eva Gonzalez et al.
CELL CYCLE (2009)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
New molecular targets for hepatocellular carcinoma: the ErbB1 signaling system
Carmen Berasain et al.
LIVER INTERNATIONAL (2007)
Early and late recurrence after liver resection for hepatocellular carcinoma - Prognostic and therapeutic implications
N Portolani et al.
ANNALS OF SURGERY (2006)
Critical update and emerging trends in epidermal growth factor receptor targeting in cancer
J Baselga et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis
E Schiffer et al.
HEPATOLOGY (2005)
Signal transduction pathways: The molecular basis for targeted therapies
SP Ethier
SEMINARS IN RADIATION ONCOLOGY (2002)
Epidermal growth factor receptors as a target for cancer treatment: The emerging role of IMC-C225 in the treatment of lung and head and neck cancers
RS Herbst et al.
SEMINARS IN ONCOLOGY (2002)
Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference
J Bruix et al.
JOURNAL OF HEPATOLOGY (2001)
Share Paper
